Why the new normal in global health requires a new access model
Development financing has changed permanently. Axmed Global Health Advisory's Access360 framework builds access strategy into product development.
Axmed Global Health Advisory
1 minute read
Share on WhatsAppScientific progress in global health has outpaced the systems designed to deliver it. This white paper from Axmed Global Health Advisory sets out Axmed’s Access360© Framework and Fingerprint for embedding access strategy earlier and more systematically in product development.
The Framework is designed to help organizations realise their access ambition through a diagnostic of internal readiness, external realities, partnerships, financing models and delivery pathways. This informs a go-to-market strategy, a practical and executable access roadmap to reach patients in LMICs.
Access360 white paper
PDF, 7.8 MB
Insights
Keep reading

Restless: what AHMTEC told me about AI and access to medicines
Reflections after AHMTEC on will, sovereignty and the chance to leapfrog with AI
Sofia Radley-Searle

Is Regulatory Approval The Happy Ever After? What Comes After the 'Regulatory Finish Line'
Reflections from PharmaReg AfriSummit 2026 on connecting regulatory approval, procurement, financing and logistics to real patient access.

How we are making pharmaceutical quality scalable and accessible with AI
How Axmed turns day-long manual prequalification and GMP and GDP audit work into real-time quality intelligence with AI. By Sofia Radley-Searle, COO.
Sofia Radley-Searle